Product NDC: | 52125-414 |
Proprietary Name: | Novolin70/30 |
Non Proprietary Name: | Human Insulin |
Active Ingredient(s): | 100 [USP'U]/mL & nbsp; Human Insulin |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52125-414 |
Labeler Name: | REMEDYREPACK INC. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019991 |
Marketing Category: | NDA |
Start Marketing Date: | 20130613 |
Package NDC: | 52125-414-01 |
Package Description: | 10 mL in 1 VIAL (52125-414-01) |
NDC Code | 52125-414-01 |
Proprietary Name | Novolin70/30 |
Package Description | 10 mL in 1 VIAL (52125-414-01) |
Product NDC | 52125-414 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Human Insulin |
Dosage Form Name | INJECTION, SUSPENSION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20130613 |
Marketing Category Name | NDA |
Labeler Name | REMEDYREPACK INC. |
Substance Name | INSULIN HUMAN |
Strength Number | 100 |
Strength Unit | [USP'U]/mL |
Pharmaceutical Classes | Insulin [Chemical/Ingredient],Insulin [EPC] |